Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Chemotherapy-induced peripheral neurotoxicity: a critical analysis.

Park SB, Goldstein D, Krishnan AV, Lin CS, Friedlander ML, Cassidy J, Koltzenburg M, Kiernan MC.

CA Cancer J Clin. 2013 Nov-Dec;63(6):419-37. doi: 10.3322/caac.21204. Review.

2.

Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.

Beijers AJ, Jongen JL, Vreugdenhil G.

Neth J Med. 2012 Jan;70(1):18-25. Review.

3.

Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies.

Park SB, Krishnan AV, Lin CS, Goldstein D, Friedlander M, Kiernan MC.

Curr Med Chem. 2008;15(29):3081-94. Review.

PMID:
19075655
4.

Nerve excitability assessment in chemotherapy-induced neurotoxicity.

Park SB, Lin CS, Kiernan MC.

J Vis Exp. 2012 Apr 26;(62). pii: 3439. doi: 10.3791/3439.

5.

Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients: the introduction of a new measure.

Driessen CM, de Kleine-Bolt KM, Vingerhoets AJ, Mols F, Vreugdenhil G.

Support Care Cancer. 2012 Apr;20(4):877-81. doi: 10.1007/s00520-011-1336-0. Epub 2011 Dec 9.

6.

Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors.

Tofthagen C, Donovan KA, Morgan MA, Shibata D, Yeh Y.

Support Care Cancer. 2013 Dec;21(12):3307-13. doi: 10.1007/s00520-013-1905-5. Epub 2013 Aug 1.

PMID:
23903798
7.

Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.

Grisold W, Cavaletti G, Windebank AJ.

Neuro Oncol. 2012 Sep;14 Suppl 4:iv45-54. doi: 10.1093/neuonc/nos203. Review.

8.

Clearing the air: a review of our current understanding of "chemo fog".

O'Farrell E, MacKenzie J, Collins B.

Curr Oncol Rep. 2013 Jun;15(3):260-9. doi: 10.1007/s11912-013-0307-7. Review.

PMID:
23483375
9.

Chemotherapy-induced peripheral neurotoxicity.

Cavaletti G, Marmiroli P.

Expert Opin Drug Saf. 2004 Nov;3(6):535-46. Review.

PMID:
15500413
10.

Impact of oxaliplatin-induced neuropathy: a patient perspective.

Bennett BK, Park SB, Lin CS, Friedlander ML, Kiernan MC, Goldstein D.

Support Care Cancer. 2012 Nov;20(11):2959-67. doi: 10.1007/s00520-012-1428-5. Epub 2012 Mar 17.

PMID:
22426503
11.

Testicular cancer survivorship: research strategies and recommendations.

Travis LB, Beard C, Allan JM, Dahl AA, Feldman DR, Oldenburg J, Daugaard G, Kelly JL, Dolan ME, Hannigan R, Constine LS, Oeffinger KC, Okunieff P, Armstrong G, Wiljer D, Miller RC, Gietema JA, van Leeuwen FE, Williams JP, Nichols CR, Einhorn LH, Fossa SD.

J Natl Cancer Inst. 2010 Aug 4;102(15):1114-30. doi: 10.1093/jnci/djq216. Epub 2010 Jun 28. Review.

12.

Role of erythropoeitin in prevention of chemotherapy-induced peripheral neuropathy.

Kassem LA, Yassin NA.

Pak J Biol Sci. 2010 Jun 15;13(12):577-87. Review.

PMID:
21061908
13.

[Chemotherapy-induced peripheral neuropathy: an unresolved issue].

Velasco R, Bruna J.

Neurologia. 2010 Mar;25(2):116-31. Review. Spanish.

14.

The pathophysiology of oxaliplatin-induced neurotoxicity.

Kiernan MC, Krishnan AV.

Curr Med Chem. 2006;13(24):2901-7.

PMID:
17073636
15.

Peripheral nerve damage associated with administration of taxanes in patients with cancer.

Argyriou AA, Koltzenburg M, Polychronopoulos P, Papapetropoulos S, Kalofonos HP.

Crit Rev Oncol Hematol. 2008 Jun;66(3):218-28. doi: 10.1016/j.critrevonc.2008.01.008. Epub 2008 Mar 7. Review.

PMID:
18329278
16.

Animal models of chemotherapy-evoked painful peripheral neuropathies.

Authier N, Balayssac D, Marchand F, Ling B, Zangarelli A, Descoeur J, Coudore F, Bourinet E, Eschalier A.

Neurotherapeutics. 2009 Oct;6(4):620-9. doi: 10.1016/j.nurt.2009.07.003. Review.

PMID:
19789067
17.

[Neurotoxicity and dermatologic toxicity of cancer chemotherapy].

Nakane M.

Gan To Kagaku Ryoho. 2006 Jan;33(1):29-33. Japanese.

PMID:
16410694
18.

Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?

Cavaletti G, Alberti P, Marmiroli P.

Am Soc Clin Oncol Educ Book. 2015:e553-60. doi: 10.14694/EdBook_AM.2015.35.e553. Review.

19.

Chemotherapy-induced neuropathy: A comprehensive survey.

Miltenburg NC, Boogerd W.

Cancer Treat Rev. 2014 Aug;40(7):872-82. doi: 10.1016/j.ctrv.2014.04.004. Epub 2014 Apr 18. Review.

PMID:
24830939
20.

Platinum-induced neurotoxicity and preventive strategies: past, present, and future.

Avan A, Postma TJ, Ceresa C, Avan A, Cavaletti G, Giovannetti E, Peters GJ.

Oncologist. 2015 Apr;20(4):411-32. doi: 10.1634/theoncologist.2014-0044. Epub 2015 Mar 12. Review.

Items per page

Supplemental Content

Write to the Help Desk